Recce Pharmaceuticals diabetic foot treatment offers strong commercial potential;...
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has been highlighted as a stock potentially poised for significant growth by Edison Research, based on the potential to commercialise its synthetic anti-infective platform, specifically its topical treatment …